Introduction
============

Dyslipidemia is closely related to the development of cardiovascular and cerebrovascular diseases, such as atherosclerosis, acute myocardial infarction, ischemic heart disease, and cerebrovascular accident, and therefore of great relevance for public health ([@B3]; [@B31]). It is estimated that 53% of American adults have lipid abnormalities ([@B42]). In Brazil, according to [@B1], the prevalence of dyslipidemia among children and adolescents enrolled in the public school system was 25.5%. They also found a positive association between dyslipidemia and overweight ([@B1]). Worldwide, in 2015, the number of overweight children under five years old had been estimated at more than 42 million ([@B47]).

Dyslipidemias, as well as obesity, are mainly multifactorial traits, influenced by the environment, genetic factors, and life habits. Polymorphisms of the *APOB*, *APOE*, *ADIPOQ*, *PLIN4*, and *HSD11*β*1* genes are important examples of genetic causes associated with dyslipidemias and obesity. The genetic variants selected for this study seem to have functional effects, being involved in lipid metabolism and features related to obesity ([@B23]; [@B38]; [@B33]; [@B4]; [@B16]; [@B21]; [@B22]; [@B27]; [@B20]; [@B37]).

The APOE glycoprotein plays an important role in metabolism, transport, and redistribution of molecules that carry cholesterol and other lipids ([@B36]). It is encoded by a gene of the same name (19q13.2) and mediates the uptake of chylomicrons, very low-density lipoprotein (VLDL) and intermediate density lipoprotein (IDL) ([@B29]; [@B46]). The ε2, ε3, and ε4 alleles (rs7412: NM_000041.3:c.526C \> T and rs429358: NM_000041.3:c.388T \> C) are combined in two important positions ([@B46]), producing therefore the three APOE major isoforms E2 (Cys 112, Cys 158), E3 (112 Cys, Arg 158), and E4 (Arg 112, Arg 158) ([@B16]; [@B21]; [@B22]). ApoB-100 is encoded by the *APOB* gene (2p24.1) and it is present on the surface of LDLs ([@B8]; [@B23]). The R3500Q mutation (rs5742904: NM_000384.2:c.10580G \> A) leads to diminished affinity for its receptor ([@B23]; [@B38]; [@B33]).

*PLIN4* (19p13.3; Ensembl 2015) participates in the Perilipin/ADRP/TIP47 (*PAT*) family of lipid storage droplet (LSD) proteins and appears to be involved in the storage of lipids in adipocytes ([@B9]). The rs8887 (NM_001080400.1:c.\*2270A \> G) polymorphism is situated in the 3'UTR region of *PLIN4* gene. The less frequent allele of this site may induce a reduction of up to 20% in the PLIN4 level due to the creation of a miR-522 binding site in the 3'UTR region of the gene ([@B37]).

The human gene encoding adiponectin, *ADIPOQ* gene (3q27), is the most expressed gene in adipose tissue ([@B28]). Obesity, and in particular the accumulation of abdominal visceral fat, as well as type 2 diabetes mellitus, coronary disease, and arterial hypertension are accompanied by a reduction of serum adiponectin ([@B4]; [@B27]). The SNP of the *ADIPOQ* gene was rs1501299: NM_001177800.1:c.214+62G \> T.

The *HDS11*β*1* gene (1q32.2; Ensembl, 2015) encodes the enzyme hydroxysteroid dehydrogenase type 1 (11β-HSD1), which is responsible for the conversion of inactive to active cortisol, in addition to regulating the interaction of cortisol with glucocorticoid receptors ([@B10]). Transgenic rats that overexpress this enzyme in adipose tissue develop visceral obesity, insulin resistance, hyperglycemia, and hyperlipidemia ([@B32]). Among its polymorphisms are rs846910 (NM_001206741.1:c.-48-2986A \> G), which corresponds to a non-coding region SNP of the *HSD11*β*1* gene, and rs12086634 (NM_001206741.1:c.332-29T \> G), which occurs in an enhancer region in intron 3 ([@B20]).

Hence, the aim of the present study was to investigate possible influences of the *PLIN4* (rs8887), *APOB* (rs5742904), *ADIPOQ (*rs1501299), *HSD11*β*1* (rs848910 and rs12086634), and *APOE* (rs7412 and rs429358; alleles ε2, ε3, and ε4) genes on lipid and glucose levels, abdominal circumference, and obesity in a sample of children and adolescents from a population in southern Brazil.

Subjects and Methods
====================

Subjects
--------

The sample was comprised of 393 Euro-Brazilians (13.54 ± 0.095 years old) living in Curitiba, PR, of which 143 were eutrophic and 250 overweight. Of these 393 individuals, 128 were girls (21.09% eutrophic and 78.91% overweight) and 265 were boys (43.94% eutrophic and 56.06% overweight). This study was approved by the Institutional Ethics Committee and informed consent was signed by participants and their parents or legal guardians.

Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m). Age- and sex-specific BMI z-score and percentiles were calculated using CDC 2000 growth charts ([@B25]). Eutrophic was defined as a \< 85 percentile, overweight as a ≥85 percentile, and obesity as ≥95 percentile. The abdominal circumference (AC) was measured in centimeters (cm) at the level of the iliac crest. Thus, subjects were classified as eutrophic (percentile \< 85) and overweight/obese (percentile ≥ 85) ([@B25]).

Blood samples were collected in the morning after 12 hours of fasting to perform measurements of glucose (Glu), triglycerides (TG), total cholesterol (TC), and high density lipoprotein cholesterol (HDL-C) by standard automated methods. Low density lipoprotein cholesterol (LDL-C) levels were calculated using the Friedewald equation ([@B17]), for TG levels below 200 mg/dL.

Genotyping assays
-----------------

DNA was extracted from peripheral blood by a salting-out method ([@B26]) and was diluted to 20 ng/μL. All SNPs were genotyped by TaqMan allelic discrimination assay on StepOnePlus real time PCR systems (Applied Biosystems, USA). Each reaction contained 3.0 μL of Master Mix (2X), 1.7 μL of ultrapure water, 0.3 μL of primer and 3.0 μL of DNA. The reactions were performed according to the following protocol: 50 °C for 2 min, 95 °C for 10 min, and 50 cycles of 95 °C for 15 s and 62 ºC for 1 min.

Statistical analysis
--------------------

Samples were classified into two groups, eutrophic and overweight *(overweight + obese),* categorized into above and below the median for age, AC, Glu, TC, LDL-C, HDL-C and TG levels. Chi-square tests were performed using Clump ([@B24]) to test for Hardy-Weinberg equilibrium and to compare allele proportions between groups above and below the median and also between eutrophic and overweight. Logistic regression analyses were performed to identify variables influencing serum glucose, lipid concentrations, and AC. False discovery rate (FDR) corrections ([@B6]) were performed for multiple testing. The significance level adopted was 0.05 (5%).

Results
=======

A descriptive analysis of the sample, displaying the variables considered in this study, is shown in [Table 1](#t1){ref-type="table"}. Significantly higher frequencies were found for the ε4 allele in the group below the HDL-C median (*p*=0.0001), and for the ε2 allele in the group below the LDL-C median (*p*=0.0001). Furthermore the ε3 allele was associated with higher AC and excess weight (*p*=0.0001). The allele frequencies are shown in [Table 2](#t2){ref-type="table"}. Logistic regression analysis was done using stratified TC as below and above the median as the dependent variable, and for the polymorphisms analyzed (dominant model for *APOE* gene, in which ε4 is dominant over ε2; for the other polymorphisms, dominant, recessive, and additive models were tested), gender, AG, and anthropometric classification as independent variables. The same logistic regression analysis design was performed using LDL-C, HDL-C, TG, glucose, and AC as the dependent variable and maintaining the same independent variables. We identified the *APOE* gene ε4 allele as a contributing factor in reducing HDL-C levels (β = -0.29 ± 0.08, *p*=0.015) and the ε3 allele as a risk factor for higher AC measures (β = -0.24 ± 0.08, *p*=0.041). We also found that obesity and overweight are independent risk factors for higher triglyceride levels (β = 0.30 ± 0.08, *p*=0.021).

###### Descriptive statistics for age, lipid profile, glucose, and abdominal circumference of the 393 individuals analyzed in this study.

  Variable[^\*^](#tfn1){ref-type="table-fn"}   N[^\*\*^](#tfn2){ref-type="table-fn"}   Mean ± SE       Median    Variance   SD      Boys mean ± SE   Girls mean ± SE
  -------------------------------------------- --------------------------------------- --------------- --------- ---------- ------- ---------------- -----------------
  Age                                          393                                     13.54 ± 0.095   13.96     3.56       1.89    13.54 ± 0.12     13.54 ± 0.17
  HDL-C (mg/dL)                                369                                     47.59 ± 0.89    46.00     116.203    10.78   45.44 ± 0.63     51.69 ± 1.02
  LDL-C (mg/dL)                                262                                     91.36 ± 1.85    87.50     898.187    29.97   89.93 ± 2.53     92.94 ± 2.72
  TG (mg/dL)                                   367                                     99.17 ± 2.88    81.74     3055.92    55.28   96.06 ± 3.35     105.05 ± 5.41
  TC (mg/dL)                                   262                                     162.67 ± 2.19   158.095   1261.96    35.52   160.42 ± 2.98    165.19 ± 3.24
  Glu (mg/dL)                                  387                                     89.50 ± 0.56    89.00     120.842    10.99   90.60 ± 0.72     87.25±0.83
  AC (cm)                                      291                                     83.69 ± 1.07    81.50     333.001    18.25   80.77 ± 1.21     92.25±1.94

High Density Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein Cholesterol (LDL-C), Triglycerides (TG), Total Cholesterol (TC), Glucose (Glu), Abdominal Circumference (AC).

393 individuals were analyzed.

###### Comparisons of allele frequencies between groups below and above the median for the analyzed variables, and between eutrophic and overweight/obese individuals.

  Alleles                         Above TC (mg/dL) median   Below TC (mg/dL) median   Above LDL-C (mg/dL) median   Below LDL-C (mg/dL) Median    Above TG (mg/dL) median   Below TG (mg/dL) median   Above HDL-C (mg/dL) median   Below HDL-C (mg/dL) median     Above AC (cm) median           Below AC (cm) median   Eutrophic            Overweight / Obese
  ------------------------------- ------------------------- ------------------------- ---------------------------- ----------------------------- ------------------------- ------------------------- ---------------------------- ------------------------------ ------------------------------ ---------------------- -------------------- -------------------------------
  ε2 *(APOE* gene)                3.57 ± 0.28 (6)           7.14 ± 0.55 (12)          1.83 ± 0.14 (3)              8.72 ± 0.66 (15) *p=*0.0001   4.84 ± 0.31 (12)          5.23 ± 0.32 (14)          4.92 ± 0.30 (13)             5.12 ± 0.32 (13)               6.25±0.49 (10)                 2.31 ± 0.15 (5)        3.70±0.25 (8)        5.36 ± 0.29 (18)
  ε3 *(APOE* gene)                82.14 ± 6.34(138)         81.55 ± 6.29 (137)        82.93 ± 6.48(136)            80.81 ± 6.16 (139)            78.22 ± 4.97 (194)        79.10 ± 4.83(212)         84.85 ± 5.22 (224)           72.44 ± 4.54(184)              71.88 ± 5.68(115) *p=*0.0001   71.30 ± 4.85(154)      76.39 ± 5.20 (165)   78.87 ± 4.30 (265) *p=*0.0001
  ε4 *(APOE* gene)                14.29 ± 1.35 (24)         11.31 ± 1.31 (19)         15.24 ± 1.32 (25)            10.47 ± 1.30 (18)             16.94 ± 1.35 (42)         15.67 ± 1.24 (42)         22.44 ± 1.70 (27)            10.23 ± 0.88 (57) *p=*0.0001   21.87 ± 2.17 (35)              26.39 ± 1.95 (57)      19.91 ± 1.59 (43)    15.77 ± 1.12 (53)
  G (rs846910 *HSD11*β*1* gene)   88.96 ± 2.52 (137)        90.85±2.25 (149)          88.19 ± 2.69 (127)           91.38 ± 2.13 (159)            88.75 ± 2.04 (213)        84.8 ± 2.27 (212)         87.5 ± 2.07 (224)            85.59 ± 2.28 (202)             87.86 ± 2.76 (123)             80.58±2.76 (166)       80.84 ± 2.69 (173)   89.42 ± 1.74 (279) *p=*0.039

\* Only the significant findings (

p

\< 0.05) are demonstrated in this table with

p

-value.

\* High Density Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein Cholesterol (LDL-C), Triglycerides (TG), Total Cholesterol (TC) , Glucose (Glu), Abdominal Circumference (AC)

\* The

n

of these groups are demonstrated between parentheses.

Furthermore, we observed that the A allele (rs846910) of the *HSD11*β*1* gene was associated with excessive weight (*p*=0.039, Chi-square test). It is known that there is variation in metabolic processes inherent to gender, so we conducted the same analyses separately for each gender. We observed that in girls the alleles ε2 and ε4 of the *APOE* gene were associated with LDL-C below the median (*p*=0.0001 by Chi-square test) and HDL-C below the median, independently of the other analyzed variables (β = -0.34 ± 0.08, *p*=0.0039) ([Table 3](#t3){ref-type="table"}). Furthermore, eutrophic girls had lower mean TG levels than obese or overweight girls (β = 0.30 ± 0.08, *p*=0.0039). Regarding boys, we observed that the ε2 allele is associated to lower LDL-C levels (*p*=0.019 by Chi-square test) ([Table 3](#t3){ref-type="table"}).

###### Comparisons of *APOE* allele frequencies between groups below and above the median for the analyzed variables, and between eutrophic and overweight/obese individuals stratified by sex.

  Alleles in Girls Group            CT (mg/dl)          LDL-C (mg/dl)       TG (mg/dl)          HDL-C (mg/dl)                AC (cm)              Obesity status                                                                                                                          
  --------------------------------- ------------------- ------------------- ------------------- ---------------------------- -------------------- -------------------- -------------------- ------------------------------ -------------------- -------------------- -------------------- -------------------------------
  ε2 (APOE - rs7412 and rs429358)   2.33±0.25 (2)       7.14 ± 0.85 (5)     1.22 ± 0.14 (1)     8.11 ± 0.94 (6) *p*=0.0001   2.44 ± 0.27 (2)      6.25±0.70 (5)        5.21 ± 0.53 (5)      3.03 ± 0.37 (2)                0.00 ± 0.00 (0)      0.00 ± 0.00 (0)      3.12 ± 0.55 (1)      4.55 ± 0.40 (6)
  E3 (APOE - rs7412 and rs429358)   83.72 ± 9.03 (72)   82.86 ± 9.90 (58)   84.15 ± 9.29 (69)   82.43±9.58 (61)              82.93 ± 9.16 (68)    81.25±9.08 (65)      87.5 ± 8.93 (84)     74.24 ± 9.14 (49)              66.67 ± 11.11 (24)   68.75 ± 12.15 (22)   84.38 ± 14.91 (27)   81.06 ± 7.06 (107) *p*=0.0001
  ε4 (APOE - rs7412 and rs429358)   13.95 ± 1.74 (12)   10.00 ± 1.86 (7)    14.63 ± 1.75 (12)   9.46 ± 1.81 (7)              14.63 ± 1.86 (12)    12.5 ± 1.98 (10)     7.29 ± 1.16 (7)      22.73 ± 3.15 (15) *p*=0.0039   33.33 ± 5.56 (12)    31.25±5.52 (10)      12.5 ± 2.71 (4)      14.39 ± 1.60 (19)
  Alleles in Boys Group             CT                  LDL-C               TG                  HDL-C                        AC                                                                                                                                                           
                                    Above the median    Below the median    Above the median    Below the median             Above the median     Below the median     Above the median     Below the median               Above the median     Below the median     Eutrophic            Overweight/ obese
  ε2 (APOE - rs7412 and rs429358)   5.81 ± 0.63 (5)     6.38 ± 0.66 (6)     3.84 ± 0.44 (3)     7.84 ± 0.78 (8) *p*=0.019    6.79 ± 0.53 (11)     4.17 ± 0.30 (8)      5.00 ± 0.37 (9)      5.68 ± 0.43 (10)               7.35 ± 0.63 (10)     2.91 ± 0.22 (5)      3.80 ± 0.28 (7)      5.88 ± 0.41 (12)
  ε3 (APOE - rs7412 and rs429358)   81.40 ± 8.78 (70)   79.79 ± 8.23 (75)   79.49 ± 9.00 (62)   81.37 ± 8.06 (83)            74.69 ± 5.87 (121)   79.16 ± 5.71 (152)   81.67 ± 6.09 (147)   72.73 ± 5.48 (128)             73.53 ± 6.30 (100)   71.51 ± 5.45 (123)   75.00 ± 5.53 (138)   77.45 ± 5.42 (158)
  ε4 (APOE - rs7412 and rs429358)   12.79 ± 1.91 (11)   13.83 ± 1.98 (13)   16.67 ± 2.28 (13)   10.79 ± 1.67 (11)            18.52 ± 1.92 (30)    16.67 ± 1.47 (32)    13.33 ± 1.31 (24)    21.59 ± 2.01 (38)              19.12 ± 2.18 (26)    25.58±2.16 (44)      21.20 ± 1.82 (39)    16.67 ± 1.52 (34)

\* Only the significant findings (

p

\< 0.05) are demonstrated in this table with

p

-value.

\* High Density Lipoprotein Cholesterol (HDL-C), Low Density Lipoprotein Cholesterol (LDL-C), Triglycerides (TG), Total Cholesterol (TC), Glucose (Glu), Abdominal Circumference (AC).

\* The

n

of these groups are demonstrated between parentheses.

Discussion
==========

Blood lipid levels are influenced by environmental and genetic factors ([@B12]), and it is known that LDL-C is the primary target for reducing cardiovascular risk ([@B11]). In our study, as shown in [Figure 1](#f1){ref-type="fig"}, it was observed that the *APOE* ε2 allele was associated with lower LDL-C levels in the total sample, as well as in girls and boys, which is consistent with the known protective effect of this allele ([@B18]; [@B7]; [@B19]; [@B45]; [@B35]; [@B5]; [@B15]). Our finding is particularly relevant considering that the protective effect of the ε2 allele is usually observed in adults, but in our study we observed that it is also present in children and adolescents, and therefore can contribute to lower LDL-C levels early in life.

![Relationships between allelic variants and analyzed variables.](1415-4757-GMB-1678-4685-GMB-2017-0195-gf01){#f1}

The *APOE*-ε4 allele seems to be associated with lower HDL-C levels, which support the notion that the ε4 allele is an atherogenic risk factor ([@B18]; [@B7]; [@B19]; [@B45]). Being related to lower HDL-C levels, responsible for cholesterol reverse transport, this allele could contribute to higher cholesterol levels, and this is especially worrisome in children, considering all possible and severe comorbidity ([@B3]; [@B31]; [@B12]).

Besides its association with the lipid profile, some studies have demonstrated that the *APOE* gene influences characteristics of obesity ([@B44]; [@B41]). According to the Atherosclerosis Risk in Communities (ARIC) study, the apo E genotypes were associated with BMI following the order: apo E4 \> apo E3 \> apo E2 ([@B44]). [@B39], who analyzed a sample of children and adolescents, similar to this study, found that the apo E3 group showed significant associations with obesity measures and lipoprotein variables.

Our work is in agreement with [@B40] who also found some increased variables, such as BMI and LDL-C, in ε3 allele carriers when compared to ε2 allele carriers in the non-metabolic syndrome group ([@B40]). Some studies also have associated the ε4 allele with features related to obesity in different populations ([@B41]; [@B2]). Therefore, these polymorphisms in the *APOE* gene influence both lipid profile and traits related to obesity. It is important to highlight the relevance of studies involving this gene, especially in the young. We found a relationship between the G allele of the *HSD11*β*1* gene rs846910 polymorphism and higher AC measurements. Some studies have demonstrated different effects of this polymorphism on serum lipid levels and other associated characteristics ([@B34]; [@B14]; [@B13]). Different from this study, [@B14] observed an association between the A allele and higher triglyceride levels, and according to some studies this polymorphism could be associated to metabolic syndrome ([@B34]; [@B14]; [@B13]). However, [@B43] found that the A allele ws associated with higher HDL-C levels only in women. Furthermore, it is relevant to consider that a possible linkage disequilibrium might exist with another polymorphism in the *HSD11*β*1* gene, and another allele could be the cause of an altered lipid profile or features related to obesity ([@B30]).

Although our study had relevant findings, we recognize that the small sample size is a limitation, thus generalizability should be done with caution, and studies with larger samples should be done. In summary, we found that in children and adolescents, as in adults, the ε4 and ε3 alleles could be considered a contributing factor for dyslipidemia and traits related to obesity, respectively, while the ε2 allele seems to be a protective factor, contributing to lower LDL-C and higher HDL-C levels. Furthermore, the *HSD11*β*1* gene G allele seems to be related to obesity. Considering that effects may start early in life, a precocious intervention could be planned, therefore preventing many complications resulting from altered lipid profile and obesity.

This work was financially supported by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior). The third author was supported by a research fellowship from CNPq (Conselho Nacional de Desenvolvimento Tecnológico e Científico).

*Associate Editor: Maria Rita Passos-Bueno*
